3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
440
Rectal Neoplasms
209
Colonic Neoplasms
201
Pancreatic Neoplasms
131
Stomach Neoplasms
116
Neoplasm Metastasis
97
Neoplasms
63
Esophageal Neoplasms
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Lymphoma
49
Leukemia
41
Carcinoma, Hepatocellular
40
Adenocarcinoma Of Esophagus
37
Burkitt Lymphoma
33
Adenocarcinoma
29
Cholangiocarcinoma
26
Biliary Tract Neoplasms
22
Carcinoma, Non-Small-Cell Lung
21
Gastrointestinal Neoplasms
20
Lymphoma, Non-Hodgkin
19
Gallbladder Neoplasms
19
Esophageal Squamous Cell Carcinoma
15
Osteosarcoma
14
Bile Duct Neoplasms
14
Unspecified Adult Solid Tumor, Protocol Specific
13
Lymphoma, Large B-Cell, Diffuse
13
Liver Neoplasms
13
Leukemia, Biphenotypic, Acute
13
Ovarian Neoplasms
12
Leukemia, Myeloid, Acute
12
Interventions
Cyclophosphamide
22
blinatumomab
18
Cytarabine
15
fludarabine
13
Azacitidine
12
venetoclax
10
fludarabine phosphate
10
Rituximab
8
Lenalidomide
7
Dexamethasone
7
Methotrexate
6
Daunorubicin
6
Mercaptopurine
5
daratumumab
4
Whole-Body Irradiation
4
Vincristine
4
Melphalan
4
Idarubicin
4
Etoposide
4
Busulfan
4
pembrolizumab
3
obinutuzumab
3
Radiotherapy
3
Maintenance
3
Immunotherapy, Adoptive
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Drug Therapy
3
Cladribine
3
Asparaginase
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm, Residual
×
Leucovorin
×
Clear all
NCT05427669
2022-10-07
AFFORD
Sun Yat-sen University
Phase 3
Not yet recruiting
340 enrolled